First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer
7 outletsin 1 language and 1 countryFirst reported , latest
People and organizations
Named in this story's headlines. Add any of them to CRM by Hottub; nothing is saved until you press Add there.
- United States Food and Drug AdministrationOrganizationAdd